Document Detail


Who gets measles in Europe?
MedLine Citation:
PMID:  21666185     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Measles outbreaks continue to occur in Europe as a result of suboptimum vaccination coverage. This article aims to describe individuals susceptible to measles, and provide an overview of affected groups and the public settings in which measles transmission occurred in Europe in 2005-2009.
METHODS: Individuals susceptible to measles were described and categorized on the basis of factors leading to nonvaccination and vaccine failure. A literature search was conducted to identify affected groups and public settings in which measles transmission occurred.
RESULTS: Most individuals susceptible to measles are previously uninfected and unvaccinated. The reasons for nonvaccination in individuals eligible for vaccination ranged from lack of information to poor access to health care. Several outbreaks have emerged in Roma and Sinti, Traveller, anthroposophic, and ultra-orthodox Jewish communities, and immigrants identifying them as being particularly at risk. Public settings for transmission included mostly educational and health care facilities.
CONCLUSIONS: Improved efforts are needed to strengthen immunization programs, identify barriers for measles-containing vaccine uptake, and explore methods to target vulnerable populations that are not being reached with routine immunization delivery services. Specific measures are needed to prevent and control measles in educational and health care facilities. Failure to identify who gets measles and implement the elimination strategies raises concerns for the successful and sustainable elimination of measles in Europe.
Authors:
Mark Muscat
Related Documents :
9680475 - Nmr identification of epitopes of lyme disease antigen ospa to monoclonal antibodies.
21763385 - Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatiti...
16051445 - Immunodominant viral peptides as determinants of cross-reactivity in the immune system-...
19494285 - Vaccination with abeta-displaying virus-like particles reduces soluble and insoluble ce...
23583895 - Antibody responses induced in mice immunized with recombinant adenovectors expressing c...
3611115 - A comparison of an enzyme-linked immunosorbent assay and counter current electrophoresi...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  The Journal of infectious diseases     Volume:  204 Suppl 1     ISSN:  1537-6613     ISO Abbreviation:  J. Infect. Dis.     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-06-13     Completed Date:  2011-07-20     Revised Date:  2011-10-25    
Medline Journal Info:
Nlm Unique ID:  0413675     Medline TA:  J Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S353-65     Citation Subset:  AIM; IM    
Copyright Information:
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.
Affiliation:
Department of Epidemiology, Statens Serum Institut, Copenhagen, Denmark. markmuscat1@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Disease Outbreaks / statistics & numerical data
Disease Susceptibility
Europe / epidemiology
Humans
Immunization Programs
Measles / epidemiology*,  immunology
Measles Vaccine / administration & dosage*
Population Surveillance
Risk Factors
Time Factors
Chemical
Reg. No./Substance:
0/Measles Vaccine
Comments/Corrections
Erratum In:
J Infect Dis. 2011 Oct 15;204(8):1293-4

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income...
Next Document:  Progress toward measles elimination in the Russian Federation, 2003-2009.